| Product Code: ETC6348824 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The blood plasma derivative import market in Belgium saw a continued high concentration in 2024, with top exporting countries being Switzerland, Germany, USA, Netherlands, and Poland. Despite a slight decrease in growth rate from 2023 to 2024, the compound annual growth rate for the period 2020-2024 remained strong at 11.67%. This indicates a steady demand for blood plasma derivatives in Belgium, with key suppliers maintaining their significant presence in the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Blood Plasma Derivative Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Blood Plasma Derivative Market Revenues & Volume, 2021 & 2031F |
3.3 Belgium Blood Plasma Derivative Market - Industry Life Cycle |
3.4 Belgium Blood Plasma Derivative Market - Porter's Five Forces |
3.5 Belgium Blood Plasma Derivative Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Belgium Blood Plasma Derivative Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Belgium Blood Plasma Derivative Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Belgium Blood Plasma Derivative Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for blood plasma derivative products in Belgium due to the rising prevalence of diseases requiring plasma-derived therapies. |
4.2.2 Technological advancements in blood plasma fractionation techniques leading to the development of innovative plasma-derived products. |
4.2.3 Growing awareness about the benefits of blood plasma derivatives in treating various medical conditions. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for blood plasma derivative products in Belgium. |
4.3.2 High costs associated with the production and purification of blood plasma derivatives. |
4.3.3 Limited availability of plasma donors leading to supply constraints. |
5 Belgium Blood Plasma Derivative Market Trends |
6 Belgium Blood Plasma Derivative Market, By Types |
6.1 Belgium Blood Plasma Derivative Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Belgium Blood Plasma Derivative Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Belgium Blood Plasma Derivative Market Revenues & Volume, By Albumin, 2021- 2031F |
6.1.4 Belgium Blood Plasma Derivative Market Revenues & Volume, By Factor VII, 2021- 2031F |
6.1.5 Belgium Blood Plasma Derivative Market Revenues & Volume, By Factor IX concentrate, 2021- 2031F |
6.1.6 Belgium Blood Plasma Derivative Market Revenues & Volume, By Anti-coagulation factor, 2021- 2031F |
6.1.7 Belgium Blood Plasma Derivative Market Revenues & Volume, By Rh immunoglobulin, 2021- 2031F |
6.1.8 Belgium Blood Plasma Derivative Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Belgium Blood Plasma Derivative Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Belgium Blood Plasma Derivative Market Revenues & Volume, By Immunodeficiency Diseases, 2021- 2031F |
6.2.3 Belgium Blood Plasma Derivative Market Revenues & Volume, By Bleeding Disorders, 2021- 2031F |
6.2.4 Belgium Blood Plasma Derivative Market Revenues & Volume, By Liver Conditions, 2021- 2031F |
6.2.5 Belgium Blood Plasma Derivative Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Belgium Blood Plasma Derivative Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Belgium Blood Plasma Derivative Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Belgium Blood Plasma Derivative Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 Belgium Blood Plasma Derivative Market Revenues & Volume, By Transfusion Centers, 2021- 2031F |
7 Belgium Blood Plasma Derivative Market Import-Export Trade Statistics |
7.1 Belgium Blood Plasma Derivative Market Export to Major Countries |
7.2 Belgium Blood Plasma Derivative Market Imports from Major Countries |
8 Belgium Blood Plasma Derivative Market Key Performance Indicators |
8.1 Average selling price of blood plasma derivative products. |
8.2 Number of new product launches or innovations in the blood plasma derivative market. |
8.3 Patient adoption rate of blood plasma derivative therapies. |
8.4 Research and development investment in blood plasma derivative products. |
8.5 Number of plasma donation centers in Belgium. |
9 Belgium Blood Plasma Derivative Market - Opportunity Assessment |
9.1 Belgium Blood Plasma Derivative Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Belgium Blood Plasma Derivative Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Belgium Blood Plasma Derivative Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Belgium Blood Plasma Derivative Market - Competitive Landscape |
10.1 Belgium Blood Plasma Derivative Market Revenue Share, By Companies, 2024 |
10.2 Belgium Blood Plasma Derivative Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here